BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Mergers and Acquisitions (World)
Teva (TEVA) Completes Acquisition Of Auspex Pharmaceuticals (ASPX) 5/5/2015
Pfizer (PFE) Confirmed to be Mystery Bidder of $4.3 Billion Sobi 5/4/2015
OphthaliX Inc. Signs Term Sheet To Acquire Improved Vision Systems Ltd. 5/4/2015
Can-Fite BioPharma (CFBI) Subsidiary, OphthaliX, Signs Term Sheet To Acquire Improved Vision Systems Ltd. 5/4/2015
Will Pfizer (PFE) Make a Play for Struggling GlaxoSmithKline (GSK)? 4/29/2015
Mylan (MYL) Ups Bid for Perrigo (PRGO) to $32.7B, As M&A Hungry Hippos Continues 4/29/2015
Resverlogix (RVX.TO) CEO Says It's in Talks With Suitors, After $100M in Q1 Deals 4/28/2015
In Testy Letter to Teva (TEVA)'s CEO, Mylan (MYL) Rejects Its $40B Bid, Questions Credibility 4/28/2015
Sobi Waves For Sale Sign at Big Pharmas Like Pfizer (PFE), Biogen (BIIB) 4/27/2015
Teva (TEVA) Reiterates Commitment To Cash-And-Stock Acquisition Of Mylan (MYL) For $82.00 Per Share 4/27/2015
Novartis AG (NVS) Hunts for Bolt-On Acquisitions Worth $2 Billion to $5 Billion 4/24/2015
How Abbott (ABT) is Reaping Rewards From Teva (TEVA)'s Bid for Mylan (MYL) 4/23/2015
Rumors Swirl Pfizer (PFE) Will Bid for AstraZeneca PLC (AZN) Again 4/23/2015
Teva (TEVA) Files For Hart-Scott-Rodino Notification Regarding Proposed Acquisition Of Mylan (MYL) 4/22/2015
Teva (TEVA) Finally Makes Mylan (MYL) Bid Official, With $40 Billion Offer For Biggest Takeover in 2015 4/21/2015
BREAKING: Perrigo (PRGO) Rejects $30B Mylan (MYL) Bid, Says Deal "Substantially Undervalues" Irish Firm 4/21/2015
Actelion Ltd. (ALIOF.PK) CFO Actively Hunting for M&A Opportunities 4/21/2015
Daiichi Sankyo Dumps $3.6 Billion Sun Pharma (SUNPHARMA.NS) Stake 4/20/2015
Teva (TEVA) Will Bid For Mylan (MYL), Say Sources, As Tug-of-War Continues 4/20/2015
Mallinckrodt (MNK) Completes Acquisition Of Ikaria 4/17/2015
Sartorius Stedim Biotech Acquires UK-based CRO, BioOutsource 4/17/2015
Karo Bio AB Acquires Product For Treatment Of Common Cold 4/10/2015
EXCLUSIVE: Shire (SHPGY) Buyout of BioMarin (BMRN) "Seems Obvious," Source Close to the Deal Tells BioSpace (DHX) 4/2/2015
Valeant (VRX) Completes Acquisition Of Salix (SLXP) 4/1/2015
Dr. Reddy's Laboratories Ltd. (RDY) To Acquire Select Portfolio Of The Established Products Business Of UCB In India 4/1/2015
Teva (TEVA) Shells Out $3.2B to Buy Auspex Pharmaceuticals (ASPX) and Boost CNS Business; All Cash, No Debt 3/31/2015
RedHill Biopharma Ltd. (RDHL) Will Snag Small Molecule Rights from Apogee for $5.5M 3/31/2015
Japan's FUJIFILM to Acquire U.S. Cellular Dynamics for $307M 3/31/2015
Horizon Pharma (HZNP) Acquires Hyperion Therapeutics (HPTX) and Its Revenue-Boosting Pipeline for $1.1B 3/31/2015
Amneal Signs Deal To Acquire The Generic Business Of Actavis (ACT) Australia 3/31/2015
BIOSAFE Goes Direct in Brazil, Acquiring Its Local Distributor 3/30/2015
Columbia Laboratories, Inc. (CBRX) Acquires Exclusive Worldwide License To A Novel Segmented Intra-Vaginal Ring Delivery Technology 3/30/2015
Solasia Acquires Exclusive License And Distribution Rights From Camurus For Episil Oral Liquid In Japan And China 3/30/2015
Novartis AG (NVS) CEO, a San Francisco Native, Takes an Axe to Predecessor's Empire 3/27/2015
Life Post-Ranbaxy Laboratories (RANBAXY.BO)? Sun Pharma (SUNPHARMA.NS) Holds On to $300 Million and Hunts for More M&As 3/25/2015
APR Applied Pharma Research S.A. Today Announced That HBM Partners AG (“HBM”) Has Acquired A Minority Stake In APR 3/25/2015
Recent Signs Mylan (MYL) May be Gobbled Up by Teva (TEVA) 3/23/2015
Cipher Pharmaceuticals (DND.TO) Acquires Canadian Rights To Novel Treatment For Psoriasis And Rheumatoid Arthritis 3/23/2015
AstraZeneca PLC (AZN) Trudges Behind in Cancer Race Where Losing May Force a Buyout 3/20/2015
Genmab A/S (GEN.CO) Acquires Antibody Assets From iDD Biotech 3/18/2015
Pharmalink AB Acquires Novel Therapeutic Product Candidate For Treating Inflammation Associated With Osteoarthritis 3/18/2015
Ignyta (RXDX) Shells Out $41.6 Million for Teva (TEVA)'s Oncology Assets 3/18/2015
Actavis (ACT) Completes Allergan (AGN) Acquisition 3/17/2015
Valeant (VRX) Sweetens Salix (SLXP) Deal to $173 Per Share After Teaming Up With Ackman and Endo International (ENDP) Withdraws 3/16/2015
Valeant (VRX) Announces HSR Clearance For Salix (SLXP) Acquisition 3/16/2015
GlaxoSmithKline (GSK) Pockets $853 Million by Halving Stake in Aspen Pharmacare 3/13/2015
Employees at Three Major Biopharmas Remain Uncertain, As Salix (SLXP) Confirms Bid From Endo International (ENDP) 3/13/2015
Porton Fine Chemicals Pays $41.5 Million To Acquire Dongbang Pharma 3/12/2015
LMC Diabetes & Endocrinology And Manna Research Merge Research Programs 3/12/2015
AbbVie (ABBV), Johnson & Johnson (JNJ) Tempted to Take Over $650 Million Galapagos (GLPG.BR) 3/11/2015
Novartis AG (NVS) Will Move Past Scandal While Hunting for More M&A in the $2-5 Billion Range, Says CEO 3/5/2015
Baxter International (BAX) Snaps Up German Biopharma for $225 Million 3/5/2015
Teva (TEVA) Sells Plant, 25 Drugs to G&W Laboratories; 280 Jobs Salvaged 3/4/2015
Sun Pharma (SUNPHARMA.NS) Snaps Up GlaxoSmithKline (GSK)'s Opiates Business 3/3/2015
ICON Completes Acquisition Of MediMedia Pharma Solutions 3/2/2015
JSR Corporation And KBI BioPharma Agree To Acquisition; INCJ And CMIC Of Japan Also Participate 2/26/2015
Phosphagenics Limited (POH.AX) Decides To Sell BioElixia Cosmetics Brand 2/25/2015
Bristol-Myers Squibb (BMY) Snaps Up Private Cancer Drugmaker in $1.25 Billion Buyout 2/24/2015
Ipsen (IPN.PA) Enters Into Option Agreement To Acquire Canbex Therapeutics 2/24/2015
Bayer AG (BAYZF) May Have a Buyer for Diabetes Biz 2/23/2015
Ferring Pharmaceuticals Acquires Novel Drug Delivery Technology From CTCBIO Inc. 2/23/2015
EXCLUSIVE: Evercore ISI Breaks Down Valeant (VRX) / Salix (SLXP) Deal By the Numbers 2/23/2015
Shire (SHPGY) Completes Acquisition Of NPS Pharmaceuticals, Inc. (NPSP) 2/23/2015
Sosei Snags UK Biotech Firm Heptares for $400 Million 2/23/2015
Management Buy Out Of Synexus Backed By LDC; The Deal Will Enable It To Further Expand Its Global Network 2/23/2015
Actavis (ACT) to Officially Adopt Allergan (AGN) Name 2/20/2015
Ferring Pharmaceuticals Acquires Two Phase III Ready Orthobiologic Product Candidates From BioSET 2/19/2015
Endo Pharmaceuticals (ENDP) Rumored to be Battling Shire (SHPGY), Valeant (VRX) for Salix (SLXP)'s Affections 2/18/2015
Crown Bioscience, Inc. Buys PDX Unit From Molecular Response (MRL) 2/18/2015
Amneal, Pfizer (PFE), Novartis AG (NVS) Eye Takeover of CLARIS Lifesciences's Injectables Biz 2/17/2015
Week in Review: Cellular Biomedicine Group (CBMG) In-Licenses Cancer Immunotherapy From China 2/16/2015
Novartis AG (NVS) Eyes Israeli Companies 2/16/2015
Look Out Valeant (VRX), Shire (SHPGY) Wants to Continue Spending Spree With Salix (SLXP) Bid 2/16/2015
Intrexon Corporation Snaps Up Belgium Startup ActoGeniX for $60 Million 2/13/2015
GlaxoSmithKline (GSK) Takes Full Control of GlycoVaxyn AG for $190 Million 2/11/2015
BIOCEO15: Financial Panel Sees Deal-Making Up in 2015, Names CAR-T, Plaque Attackers as Hot Targets 2/9/2015
Cellular Biomedicine Group (CBMG) Acquires CAR-T Technology From China Hospital 2/9/2015
AstraZeneca PLC (AZN) Slams Down $600 Million for Actavis (ACT) Lung Unit 2/5/2015
Hainan Shuangcheng Buys Hangzhou Ausia Biotech Stake For $154 Million 2/4/2015
Harbin Gloria Pharmaceuticals (002437.SZ) Acquires Shanxi Powerdone For $380 Million 2/4/2015
Mylan Inc. (MYL) to Become a Women's Healthcare Powerhouse With $800 Million Buy 2/3/2015
ICON Snaps Up MediMedia Pharma Solutions for $120 MIllion Cash 2/2/2015
Sanofi (SAN.PA)'s Increased Stake in Alnylam Pharmaceuticals (ALNY) Points Toward a Possible Acquisition 2/2/2015
Endo Pharmaceuticals (ENDP) Completes Acquisition Of Auxilium Pharmaceuticals (AUXL) 1/30/2015
AstraZeneca PLC (AZN) Rumored to be Stalking Massachusetts's Ariad Pharmaceuticals, Inc. (ARIA) 1/29/2015
Pharma Giant Merck & Co. (MRK) Scoops Up UK Software Firm for Undisclosed Amount 1/29/2015
Actavis (ACT)' Buying Spree Continues With $460 Million Deal 1/27/2015
genae Buys e-novex 1/27/2015
Biolin Scientific Acquires The Key Patent Protecting Multi-Hole, High-Throughput Ion Channel Screening 1/27/2015
Novartis AG (NVS) CEO Taking a Hard Look at Swiss Costs, Possible Bolt-On Acquisitions 1/26/2015
3SBio Inc. (SSRX) Acquires Sirton Pharmaceuticals SpA 1/26/2015
AMATSIGROUP Acquires SEPS Pharma In Belgium, To Continue Its International Expansion And Strengthen Its Formulation Expertise 1/26/2015
Aspen Pharmacare Ltd. Grabs Rights to Novartis AG (NVS)'s Mono-Embolex for $142.3 Million 1/23/2015
With Cash in the Bank, Incoming Takeda (TKPYY) CEO Eyes M&A Opportunities 1/22/2015
Piramal Snaps Up Coldstream Laboratories Inc. for $30.65 Million 1/21/2015
Boehringer Ingelheim Corporation Considering Sale of Its U.S.-Based Generics Biz 1/19/2015
Buying Spree Continues as Roche (RHHBY) Picks Up Trophos in $540 Million Deal 1/19/2015
Fresh Off Its Biggest Buy Yet, Shire (SHPGY) Already Hints at Another One 1/13/2015
Teva Pharmaceutical Industries Limited (TEVA) May Need to Jump Onto the Takeover Bandwagon Soon 1/12/2015
Amarantus BioSciences, Inc. Announces Acquisition Of Specialized Neuro-Diagnostics Company, DioGenix 1/12/2015
Actavis (ACT) And Allergan (AGN) Announce Early Termination Of Hart-Scott-Rodino Waiting Period For Actavis' Pending Acquisition Of Allergan And Record Dates For Shareholder Meetings 1/12/2015
Shire (SHPGY) Officially Snaps Up NPS Pharmaceuticals, Inc. (NPSP) in $5.2 Billion Deal 1/12/2015
WuXi PharmaTech Co., Ltd. Acquires NextCode Health For $65 Million 1/9/2015
WuXi PharmaTech Co., Ltd. Acquires NextCode Health To Create Global Leader In Genomic Medicine 1/9/2015
BTG plc (BTG.L): Completion Of The Acquisition Of PneumRx Inc. 1/8/2015
Horizon Discovery Group plc Acquires Haplogen Genomics GmbH 1/8/2015
Advanced Accelerator Applications Fully Acquires Atreus Pharmaceuticals, Inc.; Enrolls First Patient In A Phase 1/2 Clinical Trial For Its Key Diagnostic Candidate Annexin V-128 In Rheumatoid Arthritis And Ankylosing Spondylitis 1/8/2015
Crown Bioscience, Inc. Expands Operations And Re-Brands UK Site 1/8/2015
Gilead Sciences, Inc. (GILD) Snaps Up Liver Disease Treatment from Phenex Pharmaceuticals AG in $470 Million Deal 1/6/2015
Cardio3 BioSciences Moves Into Oncology With $182 Million Deal 1/6/2015
Pfizer (PFE) Takes Controlling Interest In Startup; Grabs Access of Preclinical CMV Candidate 1/5/2015
SRF Snaps Up DuPont (DD)'s Pharma Propellant Biz for $20 Million 1/2/2015
AstraZeneca PLC (AZN) CEO Believes New Pfizer (PFE) Bid Unlikely 12/29/2014
Spending Spree Continues as Actavis (ACT) Considers Near $3 Billion Bid for Almirall 12/24/2014
Roivant Acquires SB742457 From GlaxoSmithKline (GSK) 12/23/2014
Roche (RHHBY) To Pay Up To $489 Million For Next-Gen Antibody Firm Dutalys 12/22/2014
Shire (SHPGY) May Spend AbbVie (ABBV) Breakup Fee On NPS Pharmaceuticals, Inc. (NPSP); NPS Surges On Rumor 12/19/2014
KCR Acquires Project Portfolio From Ukrainian CRO AXIS 12/18/2014
RedHill Biopharma Ltd. (RDHL) Acquires Technology From University of Minnesota As Part Of Ongoing RHB-104 Phase 3 Crohn's Program 12/18/2014
UCB SA Terminates $1.53 Billion Sale Of Generic Drug Unit To Buyout Firms 12/17/2014
Evolva A/S Unloads EV-035 Series To Emergent BioSolutions (EBS) For $70.5 Million Plus 12/17/2014
Novartis AG (NVS) Takes Stake In Israeli Biopharma BioLine; Makes $10 Million Investment 12/16/2014
Renmatix Acquires Sweden-Based REAC Fuel's Intellectual Property 12/16/2014
Sosei Group Corporation Acquires Jitsubo, A Leading Japanese Peptide Technology Company 12/12/2014
Cipla Ltd. Sells Stake In Jiangsu Cdymax Pharma For $18.5 Million 12/12/2014
Interim CEO Says Sanofi (SAN.PA) Continuing Diversification, Eyeing Acquisitions 12/10/2014
China, South Korea OK GlaxoSmithKline (GSK)'s $43B Covidien (COV) Buy 12/5/2014
Speculation Mounts That Pfizer (PFE) Will Up Bid For AstraZeneca PLC (AZN) As Cooling Off Period Ends 12/5/2014
Forbion Announces Sale Of Portfolio Company PneumRx Inc. To BTG plc (BTG.L) For Up To EUR 385M (USD 475M) 12/4/2014
Roche (RHHBY) Acquires Ariosa Diagnostics, Inc. And Enters The Non-Invasive Prenatal Test (NIPT) And Cell-Free DNA Testing Services Markets 12/3/2014
Alizé Acquires Exclusive Worldwide Rights On A New Peptide To Tackle Bone Diseases 12/3/2014
Shanghai Fosun Buys 65% Stake In Suzhou Erye Pharma 12/3/2014
Otsuka Pharmaceutical Co., Ltd. Buys AVANIR Pharmaceuticals (AVNR) For $3.5 Billion 12/2/2014
Pfizer (PFE) Announces Completion Of Merger With Wyeth 12/2/2014
European Commission (EC) Regulators Mull Novartis AG (NVS), GlaxoSmithKline (GSK) Deals As January Deadline Looms 12/1/2014
Contera Pharma Announces Acquisition By Korean Bukwang Pharmaceutical 12/1/2014
Imaflex Acquires Controlled-Release Agricultural Mulch Film Assets From Bayer AG (BAYZF) 12/1/2014
Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property 11/25/2014
AbbVie (ABBV) Acquires Manufacturing Facility In Singapore; Further Expands Capabilities In Asia 11/21/2014
Endo Pharmaceuticals (ENDP) Announces Early Termination Of HSR Act Waiting Period In Connection With Its Proposed Acquisition Of Auxilium Pharmaceuticals (AUXL) 11/19/2014
Recipharm AB Bags Lusomedicamenta For $140 Million 11/14/2014
Jubilant Life Sciences (JOL) Seeks To Complete Buyout Of U.S.-Based Cadista For Up To $33.2 Million 11/14/2014
PE Firm To Bid For GlaxoSmithKline (GSK)'s $3 Billion Mature Drugs Portfolio 11/14/2014
Sanofi (SAN.PA) Unloads Large Office In India 11/13/2014
Nuvo Research Inc. (NRI.TO) Reacquires Pennsaid® 2% Rights To South America, Central America, South Africa And Israel 11/13/2014
Thailand-Based SCG Acquires Stake In Liechtenstein-Based Research Company Lysando AG 11/12/2014
AstraZeneca PLC (AZN) Is Building Value Without Pfizer (PFE): CEO 11/11/2014
Johnson & Johnson (JNJ) Chief Eyes Acquisitions In China 11/10/2014
UCB Group (UCBJF.PK) Divests U.S. Generics Unit For $1.53 Billion 11/7/2014
GVK BIO Signs Definitive Agreement To Acquire Vanta Bioscience 11/6/2014
Perrigo (PRGO) Snatches Up Omega Pharma NV (0OMEP.BR) For $4.5 Billion 11/6/2014
AstraZeneca PLC (AZN) Builds Cancer Immunotherapy Capabilities With $150 Million Definiens AG Buy 11/4/2014
Univar Expands in Brazil Market With Acquisition Of D'Altomare Quimica Ltda. 11/4/2014
Taiyo Pacific Partners Becomes Major Shareholder In Peptidream With Stake Over 5% 11/4/2014
AbbVie (ABBV) Not Looking For Massive Deals After Abandoning Shire 11/3/2014
Actavis (ACT) And Durata Therapeutics, Inc.  (DRTX) Receive U.S. FTC Clearance For Actavis' Proposed Acquisition Of Durata 11/3/2014
Deal-Starved Perrigo (PRGO) In Exclusive Talks To Buy $5 Billion+ Omega Pharma NV (0OMEP.BR) 10/31/2014
Bayer AG (BAYZF) Hunts For More Deals After Bulking Up Consumer Care 10/30/2014
Novartis AG (NVS) Sells Flu Vaccine Business For $275 Million To CSL Limited (CMXHF.PK) 10/28/2014
Luye Pharma Pays $390 Million For Remaining 42% Of Beijing Jialin Pharma 10/28/2014
Zogenix, Inc. (ZGNX) Snags U.K.-Based Brabant Pharma In $35 Million Cash-Stock Deal 10/27/2014
Private Equity Eyes $13 Billion Bayer AG (BAYZF)'s Plastics Business 10/24/2014
Mylan Inc. (MYL), Abbott Laboratories (ABT) Tweak $5 Billion Tax Inversion Deal 10/23/2014
Therapix Signs Non-Binding Agreement to Acquire Dekel Pharmaceuticals Ltd. 10/21/2014
Actavis (ACT) Will Compete With Sanofi (SAN.PA) For $5.1 Billion Omega Pharma NV (0OMEP.BR) Deal 10/21/2014
Lupin Ltd. (LUPN.BO) Scouts For Acquisitions In U.S. 10/21/2014
Shire Goes Shopping After AbbVie (ABBV) Deal Falls Through 10/21/2014
AbbVie (ABBV) Officially Abandons Shire 10/21/2014
Fresenius AG, Buyout Groups Eye Danone Medical Nutrition Unit 10/20/2014
AbbVie (ABBV) Board Officially Abandons $55 Billion Shire Merger 10/17/2014
Virax To Acquire Deep AKT Inhibitor Portfolio Already In Phase 1b/2 Breast & Phase 1b Ovarian Cancer Trials 10/17/2014
Horizon Biopharm Pays $45 Million Cash For U.S. Rights To PENNSAID® 2% 10/17/2014
DiaGenic ASA: Completed Acquisition Of NEL Hydrogen – Company Name And Ticker To Be Changed 10/17/2014
Shire Plummets As AbbVie (ABBV) Reconsiders $55 Billion Takeover Bid 10/16/2014
Analysts Still See AstraZeneca PLC (AZN) As Viable Takeover Target 10/15/2014
Geographic Split Likely For GlaxoSmithKline (GSK) Mature Drugs Sale 10/15/2014
MorphoSys AG Acquires Lanthipeptide Technology From Lanthio Pharma 10/15/2014
Oxford BioMedica PLC (OXB.L) Acquires Windrush Court Office And Laboratory Facilities 10/13/2014
GlaxoSmithKline (GSK) Takes A 25% Stake In Aspen Pharmacare Ltd. Japanese Unit 10/9/2014
Endo International plc (ENDP) Pays $2.6 Billion For Auxilium Pharmaceuticals (AUXL), Auxilium Drops QLT Inc. (QLTI) Deal 10/9/2014
DiaGenic ASA Signed Final Agreement To Acquire NEL Hydrogen AS – Extended Announcement 10/8/2014
Teva Pharmaceutical Industries Limited (TEVA) To Stop R&D In Cancer And Women's Health; 14 Pipeline Projects To End, Divest 10/7/2014
Top Managers Argue Over What To Do With Sanofi (SAN.PA)'s $8 Billion Drug Portfolio 10/7/2014
Analyst Dismisses Teva Pharmaceutical Industries Limited (TEVA)-Mylan Inc. (MYL) Merger Rumor 10/7/2014
Week in Review: WuXi PharmaTech Co., Ltd. Acquires XenoBiotic Laboratories, Inc. , A US-China CRO 10/6/2014
Actavis (ACT) Finally Makes A Move, Pays $675 Million For Durata Therapeutics, Inc.  (DRTX) 10/6/2014
Salix Pharmaceuticals, Ltd. (SLXP) Linked With Actavis (ACT) After Calling Off Cosmo Pharmaceuticals S.p.A. Merger Amid Inversion Crackdown 10/3/2014
Immutep S.A. Picks Up Prima Biomed (PRR.AX) For $28 Million 10/2/2014
Prima Biomed (PRR.AX) Secures $37.4 Million To Fund Immutep S.A. Acquisition 10/2/2014
Consort Medical Scoops Up Aesica For $374 Million 10/1/2014
WuXi PharmaTech Co., Ltd. Laboratory Testing Division Expands In U.S. With Acquisition Of XenoBiotic Laboratories, Inc. 10/1/2014
Recipharm AB Completes Acquisition Of Corvette Pharmaceutical Services Group For SEK1.1 Billion 10/1/2014
Strides Arcolab Limited Snags Shasun Pharma In All Stock Deal Worth Over $221 Million 9/30/2014
Chiltern International Ltd. Acquires Pacific Clinical Research Pte Limited And Expands Operations And Therapeutic Depth In Asia-Pacific 9/29/2014
Daiichi Sankyo, Inc. (4568.t) Boosts Cancer Pipeline With $410 Million Ambit Biosciences Buy 9/29/2014
Hikma Pharmaceuticals Eyeing $1 Billion Bid For U.S. Rival CorePharma LLC 9/29/2014
Pfizer (PFE) Approached Actavis (ACT) For Possible Merger 9/24/2014
Merck KGaA (MKGAF.PK) To Pay $17 Billion For St. Louis-Based Sigma-Aldrich Corporation (SIAL) 9/23/2014
Bionomics Limited (BNO.AX) Acquires Prestwick Chemical 9/23/2014
Hikma Pharmaceuticals Completes Acquisition Of Ben Venue Laboratories Manufacturing Site 9/17/2014